Grant Pickering - Apr 4, 2025 Form 4 Insider Report for Vaxcyte, Inc. (PCVX)

Role
CHIEF EXECUTIVE OFFICER, Director
Signature
Grant Pickering, by /s/ Peter N. Efremenko, Attorney-In-Fact
Stock symbol
PCVX
Transactions as of
Apr 4, 2025
Transactions value $
$183,888
Form type
4
Date filed
4/7/2025, 07:38 AM
Previous filing
Mar 3, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCVX Common Stock Options Exercise $84.4K +15.8K +3.17% $5.35 514K Apr 4, 2025 Direct
transaction PCVX Common Stock Options Exercise $99.5K +4.75K +0.92% $20.93 519K Apr 4, 2025 Direct
holding PCVX Common Stock 136K Apr 4, 2025 By Children's Trust F1
holding PCVX Common Stock 136K Apr 4, 2025 By Children's Trust F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PCVX Stock Option (right to buy) Options Exercise $0 -15.8K -7.78% $0.00 187K Apr 4, 2025 Common Stock 15.8K $5.35 Direct F3
transaction PCVX Stock Option (right to buy) Options Exercise $0 -4.75K -1.57% $0.00 298K Apr 4, 2025 Common Stock 4.75K $20.93 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares are held directly by a trust for the benefit of the Reporting Person's daughter.
F2 Shares are held directly by a trust for the benefit of the Reporting Person's son.
F3 Stock Option is fully vested and exercisable.